Want to see HK:8329 full AI Analyst Report?

Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H (8329) Price & Analysis

0 Followers

8329 Stock Chart & Stats

HK$0.16

>-HK$0.01(-0.63%)

At close: Jan 09 4:00 PM EST

HK$0.16

>-HK$0.01(-0.63%)

Day’s Range― - ―

52-Week RangeHK$0.09 - HK$0.18

Previous CloseN/A

Volume90.00K

Average Volume (3M)330.65K

Market Cap

HK$182.90M

Enterprise ValueHK$22.56M

Total Cash (Recent Filing)HK$209.45M

Total Debt (Recent Filing)HK$73.02M

Price to Earnings (P/E)―

Beta0.18

Next Earnings

Aug 07, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield4.93%

Share Statistics

EPS (TTM)-0.02

Shares Outstanding426,000,000

10 Day Avg. Volume371,000

30 Day Avg. Volume330,653

Financial Highlights & Ratios

PEG Ratio0.02

Price to Book (P/B)0.37

Price to Sales (P/S)0.25

P/FCF Ratio1.92

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Low LeverageThe company's very low debt-to-equity (~0.10–0.13) provides durable financial flexibility, lowering default and refinancing risk. That conservative capital structure supports investment or dividend policy during downturns and reduces interest expense sensitivity, aiding long-term stability.

Strong Free Cash Flow (2025)Material improvement in operating cash flow and a strongly positive free cash flow in 2025 — despite a net loss — indicates the business can convert revenues to cash. That cash resilience supports capex, working capital needs and shareholder returns, giving durable funding optionality.

Positive Operating EarningsGenerating positive operating earnings even while posting a net loss shows core operations remain cash-generative before non-operating items. This suggests the underlying business model and product economics can sustain operations and recover net profitability with cost or revenue improvements.

Bears Say

Revenue DeclineA multi-year pattern of flat-to-declining top line (2025 down ~4.7%) signals weaker demand, pricing pressure, or market-share loss. Persistent revenue contraction reduces operating leverage, limits scale benefits, and makes margin recovery harder without sustainable demand or new product wins.

Margin Compression & Net LossSignificant gross-margin compression to ~29% and a return to a negative net margin (-4.2%) materially weaken earnings power. Lower margins reduce ability to absorb cost shocks, reinvest in R&D or marketing, and threaten dividend or capital allocation if losses persist.

Volatile Cash & Equity PressureHistoric swings in cash flow and a 2025 decline in equity/assets indicate balance-sheet and earnings instability. Volatility undermines planning, increases refinancing and capital-raising risk, and erodes shareholder equity, making sustained investment or payout policies less reliable.

8329 FAQ

What was Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H’s price range in the past 12 months?

Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H lowest stock price was HK$0.09 and its highest was HK$0.18 in the past 12 months.

What is Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H’s market cap?

Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H’s market cap is HK$182.90M.

When is Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H’s upcoming earnings report date?

Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H’s upcoming earnings report date is Aug 07, 2026 which is in 6 days.

How were Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H’s earnings last quarter?

Currently, no data Available

Is Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H overvalued?

According to Wall Street analysts Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H pay dividends?

Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H pays a Notavailable dividend of HK$0.164 which represents an annual dividend yield of 4.93%. See more information on Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H dividends here

What is Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H’s EPS estimate?

Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H have?

Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H has 426,000,000 shares outstanding.

What happened to Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H?

Currently, no hedge funds are holding shares in HK:8329

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology